≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Circumscribed brain atrophy

DOID EFO Endpoint Browser PheWeb

G6_ATROPHCIRCUM

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G31.0
  • Hospital discharge: ICD-9 — 3311
  • Hospital discharge: ICD-8 — 34791
  • Cause of death: ICD-10 — G31.0
  • Cause of death: ICD-9 — 3311
  • Cause of death: ICD-8 — 34791

2 out of 7 registries used, show all original rules.

695

4. Check minimum number of events

None

695

5. Include endpoints

None

695

6. Filter based on genotype QC (FinnGen only)

695

Control definitions (FinnGen only)

Control exclude
G6_NEURODEG

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF6
Parent code in ICD-10
G31
Name in latin
Atrophia cerebri circumscripta

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9185 4538 4462
Only index persons 6588 3580 3008
Unadjusted period prevalence (%)
Whole population 0.13 0.13 0.12
Only index persons 0.12 0.13 0.11
Median age at first event (years)
Whole population 66.45 69.56 63.74
Only index persons 69.18 70.86 67.17

-FinnGen-

Key figures

All Female Male
Number of individuals 695 301 394
Unadjusted period prevalence (%) 0.14 0.10 0.17
Median age at first event (years) 67.86 68.78 67.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
603
Matched controls
6027
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G31.0
ICD-10 Finland
Circumscribed brain atrophy
10351.2
323.0
409
*
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
126.6
117
*
34791
ICD-8 Finland
Other disease of brain, Atrophia cerebri
+∞
109.8
102
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.3
99.5
207
267
F03
ICD-10 Finland
Unspecified dementia
14.6
82.0
145
128
N05AX08
ATC
risperidone; systemic
11.2
79.2
161
190
TAB00
NOMESCO Finland
Lumbar puncture
17.6
73.0
118
82
N05AH04
ATC
quetiapine; oral
6.7
65.8
191
388
XA800
NOMESCO Finland
Neuropsychological investigation
16.0
64.5
108
81
N06DX01
ATC
memantine; oral
12.3
49.7
93
88
N06DA02
ATC
donepezil; oral
13.4
48.5
87
75
P20
ICPC
Memory disturbance
5.0
46.8
173
448
N05AH03
ATC
olanzapine; systemic
10.8
46.5
93
100
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.5
45.4
115
184
N03AG01
ATC
valproic acid; systemic, rectal
8.0
42.6
102
149
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
436.0
41.7
41
*
A28
ICPC
Limited function/disability NOS
3.7
35.1
188
664
G30.1
ICD-10 Finland
Alzheimer disease with late onset
13.7
34.9
61
49
P70
ICPC
Dementia
19.2
34.7
53
30
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
329.1
31.1
31
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
17.9
30.7
48
29
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.9
30.5
90
173
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
35.7
29.0
37
11
G30.0
ICD-10 Finland
Alzheimer disease with early onset
294.5
28.0
28
*
F06.7
ICD-10 Finland
Mild cognitive disorder
10.0
27.1
55
60
N06AX11
ATC
mirtazapine; oral
2.7
26.1
234
1138
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
271.6
25.9
26
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.2
25.3
83
180
N05BA04
ATC
oxazepam; oral
2.9
24.9
189
827
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.5
23.2
72
146
N06DA03
ATC
rivastigmine; oral, transdermal
9.1
23.1
49
58
N05BA06
ATC
lorazepam; systemic, sublingual
5.4
22.6
70
142
N06AB10
ATC
escitalopram; oral
3.3
21.7
125
448
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
31.3
20.7
27
9
R47.0
ICD-10 Finland
Dysphasia and aphasia
17.1
19.8
31
19
AA1AD
NOMESCO Finland
CT of head and brain
2.5
19.7
201
1018
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.7
19.1
49
78
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.2
18.9
76
202
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
+∞
18.8
18
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.5
18.3
67
163
F0203, G310
ICD-10 Finland
NA
+∞
17.8
17
*
SPAT1216
SPAT
Assessment of functional ability
2.7
17.7
144
637
R41.3
ICD-10 Finland
Other amnesia
6.2
17.3
47
81
IGY02
NOMESCO Finland
Psychiatric monitoring contact
16.6
17.2
27
17
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
14.6
16.9
28
20
N19
ICPC
Speech disorder
11.6
16.9
31
28
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
16.7
76
225
R41.0
ICD-10 Finland
Disorientation, unspecified
5.9
16.4
46
83
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.1
16.4
45
79
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
16.1
89
306
N05AD01
ATC
haloperidol; systemic
5.8
16.1
46
85
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
15.5
226
1324
N06AX16
ATC
venlafaxine; oral
3.3
15.1
79
261
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.4
15.0
76
245
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
14.9
146
708
F0204, G310
ICD-10 Finland
NA
+∞
14.6
14
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
15.9
14.5
23
15
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.1
14.0
31
40
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
18.1
13.9
21
12
R53
ICD-10 Finland
Malaise and fatigue
2.3
13.8
154
791
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
+∞
13.6
13
*
F0200, G310
ICD-10 Finland
NA
+∞
13.6
13
*
A06AD11
ATC
lactulose; oral
2.3
13.2
136
672
N06AB04
ATC
citalopram; systemic
2.3
13.0
143
731
G31
ICD-10 Finland
Other degenerative diseases of nervous system, not elsewhere classified
+∞
12.5
12
*
IGY99
NOMESCO Finland
Other psychiatric treatment contact
13.7
12.0
20
15
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
6.7
12.0
30
47
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
30.7
11.7
15
5
RT150
NOMESCO Finland
NA
+∞
11.5
11
*
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
11.5
11
*
A04
ICPC
Weakness/tiredness general
2.5
11.5
96
426
S01.0
ICD-10 Finland
Open wound of scalp
3.0
11.4
67
241
F05.9
ICD-10 Finland
Delirium, unspecified
6.1
11.3
30
51
N03AE01
ATC
clonazepam; systemic
3.4
11.3
56
178
SPAT1053
SPAT
Memory test
2.2
11.2
129
666
G12.2
ICD-10 Finland
Motor neuron disease
14.2
11.0
18
13
N03AX09
ATC
lamotrigine; oral
5.1
10.8
33
67
P28
ICPC
Limited function/disability (P)
21.9
10.7
15
7
R4130
NOMESCO Finland
Speech therapy
5.7
10.7
30
55
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.0
10.7
63
227
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
61.1
10.7
12
*
RT250
NOMESCO Finland
NA
61.1
10.7
12
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
61.1
10.7
12
*
N99
ICPC
Neurological disease other
8.7
10.6
22
26
F22.0
ICD-10 Finland
Delusional disorder
9.4
10.6
21
23
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
14.5
10.5
17
12
N05BA01
ATC
diazepam; systemic, rectal
2.4
10.5
99
463
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
12.3
10.4
18
15
G30
ICD-10 Finland
Alzheimer disease
23.8
10.3
14
6
F80.1
ICD-10 Finland
Expressive language disorder
23.8
10.3
14
6
P99
ICPC
Psychological disorders other
7.7
10.3
23
31
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.4
9.9
47
145
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
10.9
9.8
18
17
U04
ICPC
Incontinence urine
3.5
9.7
44
131
W19
ICD-10 Finland
Unspecified fall
2.6
9.7
71
292
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
15.3
9.6
15
10
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.1
9.5
29
59
P29
ICPC
Psychological sympt/compl other
4.4
9.4
33
78
F0202, G310
ICD-10 Finland
NA
+∞
9.4
9
*
F064, G310
ICD-10 Finland
NA
+∞
9.4
9
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.7
9.3
40
114
183
Kela drug reimbursment
Lamotrigin and topiramate
10.9
9.3
17
16
L28
ICPC
Limited function/disability (L)
2.0
9.1
119
647
G40
ICD-10 Finland
Epilepsy
10.3
9.1
17
17
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.4
9.0
44
968
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
8.9
183
1168
N05CF01
ATC
zopiclone; oral
1.7
8.8
219
1487
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
14.3
8.7
14
10
F06.4
ICD-10 Finland
Organic anxiety disorder
50.7
8.7
10
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
8.6
44
144
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.2
8.6
44
144
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
10.2
8.6
16
16
N05AX12
ATC
aripiprazole; systemic
6.6
8.5
21
33
SPAT1254
SPAT
Administration of medicine
2.1
8.4
103
544
WYA20
NOMESCO Finland
Home visit
6.9
8.4
20
30
A29
ICPC
General symptom/complaint other
2.2
8.4
84
406
F0201, G310
ICD-10 Finland
NA
+∞
8.3
8
*
F0633, G310
ICD-10 Finland
NA
+∞
8.3
8
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.2
8.3
19
27
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
6.2
8.2
21
35
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
22.4
8.0
11
5
P98
ICPC
Psychosis NOS/other
22.4
8.0
11
5
N05AB03
ATC
perphenazine; systemic, rectal
4.3
7.9
28
68
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
7.8
51
197
34599
ICD-8 Finland
Epilepsy, Other and unspecified
15.3
7.7
12
8
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
45.6
7.7
9
*
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
12.0
7.6
13
11
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
5.9
7.6
20
35
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
9.0
7.6
15
17
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.0
7.6
111
625
F61.0
ICD-10 Finland
Mixed personality disorders
10.2
7.6
14
14
SPAT1234
SPAT
Support of social functional capacity
2.8
7.4
45
167
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.3
7.4
26
63
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
7.3
7
*
F062, G310
ICD-10 Finland
NA
+∞
7.3
7
*
S06.0
ICD-10 Finland
Concussion
2.3
7.3
69
323
Z03
ICPC
Housing/neighbourhood problem
16.0
7.2
11
7
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
16.0
7.2
11
7
N05AF03
ATC
chlorprothixene; systemic
4.9
7.2
22
46
N06AX26
ATC
vortioxetine; oral
3.8
7.2
29
80
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
6.7
7.2
17
26
N06AB06
ATC
sertraline; oral
2.5
7.1
53
221
R55
ICD-10 Finland
Syncope and collapse
2.1
7.1
81
414
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
7.0
93
507
N28
ICPC
Limited function/disability (N)
5.3
7.0
20
39
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
7.0
38
132
N05AH02
ATC
clozapine; systemic
7.7
6.9
15
20
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
8.4
6.9
14
17
N06AX12
ATC
bupropion; oral
3.9
6.8
26
68
IGV01
NOMESCO Finland
Psychiatric network contact
40.5
6.8
8
*
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
16.9
6.8
10
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
6.7
92
506
AA400
NOMESCO Finland
Electroconvulsive therapy
22.8
6.7
9
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
6.0
6.6
17
29
SPAT1229
SPAT
Assessment of need for aid
2.2
6.6
67
327
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
10.2
6.6
12
12
F00, F03
ICD-10 Finland
NA
70.6
6.4
7
*
N05AF05
ATC
zuclopenthixol; systemic
8.3
6.4
13
16
N05CD07
ATC
temazepam; oral
1.9
6.3
100
579
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
6.3
93
526
P74
ICPC
Anxiety disorder/anxiety state
4.4
6.3
21
49
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
18.2
6.3
9
5
F06.32
ICD-10 Finland
Organic depression
18.2
6.3
9
5
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
+∞
6.3
6
*
F060, G310
ICD-10 Finland
NA
+∞
6.3
6
*
F020, G310
ICD-10 Finland
NA
+∞
6.3
6
*
N03AF01
ATC
carbamazepine; oral, rectal
2.6
6.2
42
167
G30.8
ICD-10 Finland
Other Alzheimer disease
7.1
6.2
14
20
N05AA02
ATC
levomepromazine; systemic
3.1
6.2
31
102
P72
ICPC
Schizophrenia
6.4
6.2
15
24
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.7
6.1
19
41
N05BE01
ATC
buspirone; oral
4.2
6.1
21
51
P01
ICPC
Feeling anxious/nervous/tense
2.9
6.1
35
126
79199
ICD-8 Finland
Headache
5.3
6.0
17
33

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
93
28
38.19
148.07
1.0
1.0
ng/l
37.4
26.1
1.58
74
11
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
92
28
37.72
145.99
1.0
1.0
ng/l
824.9
682.8
0.74
71
12
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
91
28
37.25
143.91
1.0
1.0
ng/l
292.7
197.9
3.03
74
11
(3009466) Valproate [Moles/volume] in Serum or Plasma
78
58
15.02
84.84
5.6
4.1
umol/l
314.7
352.1
0.96
66
50
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
90
95
10.73
78.26
1.2
1.3
e6/l
2.9
67.5
0.63
66
75
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
89
95
10.60
76.74
1.2
1.4
e6/l
1003.9
1346.4
0.11
69
77
(3044290) Cell count panel - Cerebral spinal fluid
71
86
9.08
55.32
1.1
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
51
38
14.40
55.02
1.3
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
42
38
11.70
40.11
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
236
1233
2.38
24.13
2.0
1.8
nmol/l
1184.3
1181.1
0.02
187
920
(1761868) Lipid panel - Serum or Plasma
74
1529
0.42
11.47
2.4
3.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
22
41
5.51
11.41
1.1
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
340
2472
1.73
11.34
2.4
2.1
pmol/l
91.1
94.0
0.58
188
1269
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
89
418
2.30
10.92
1.9
1.7
%
1.5
1.6
0.53
78
348
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
23
50
4.72
10.07
1.1
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
46
4.45
8.19
1.1
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
175
1143
1.71
8.07
2.9
3.3
mmol/l
2.4
2.5
2.10
137
999
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
429
5014
0.62
8.02
3.8
4.8
mmol/l
1.4
1.4
0.96
379
4485
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
124
740
1.82
7.79
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
123
736
1.82
7.65
1.9
1.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
12
9
13.54
7.40
17.9
14.0
nmol/l
1316.8
1673.7
—
12
9
(3015377) Calcium [Moles/volume] in Serum or Plasma
263
1939
1.57
7.36
2.5
3.6
mmol/l
2.3
2.3
0.74
218
1662
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
158
1039
1.67
7.01
1.9
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
417
4854
0.65
6.94
3.4
4.3
mmol/l
1.3
1.3
0.88
358
4310
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
440
5058
0.65
6.82
3.9
4.9
mmol/l
4.5
4.5
0.36
389
4565
(3019832) Treponema pallidum Ab [Presence] in Serum
36
140
2.66
6.64
1.3
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
9
12.39
6.60
14.2
10.6
nmol/l
622.1
955.2
—
11
9
(40768804) Tissue Pathology biopsy report
146
2115
0.61
6.58
1.8
2.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
455
5179
0.65
6.52
4.6
5.5
mmol/l
2.6
2.6
0.41
403
4649
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
241
1789
1.53
6.33
2.8
2.1
u/l
895.6
248.1
0.53
228
1676
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
429
4920
0.67
6.08
5.8
6.6
mmol/mol
39.8
41.0
2.08
396
4467
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
427
4899
0.67
6.03
17.6
16.2
ml/min/173m2
77.8
72.9
5.89
338
4081
(3020682) Albumin/Creatinine [Ratio] in Urine
132
1925
0.61
5.99
3.2
4.1
mg/mmol
4.0
9.3
4.35
88
1229
(3021960) Folate [Moles/volume] in Serum or Plasma
204
1488
1.53
5.72
1.7
1.6
nmol/l
20.6
20.5
0.03
188
1236
(3024561) Albumin [Mass/volume] in Serum or Plasma
316
2523
1.46
5.64
3.7
4.9
g/l
35.2
34.7
0.89
284
2339
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
74
416
1.87
5.59
1.9
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
25
4.87
5.51
1.0
1.0
u/l
1.0
1.1
—
5
15
(3006653) Thiamine [Moles/volume] in Blood
12
25
4.87
5.51
1.0
1.0
nmol/l
123.1
141.4
0.44
12
25
(3026008) Bacteria identified in Urine by Culture
243
1854
1.48
5.43
3.9
3.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
232
1762
1.48
5.27
4.4
4.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
126
1810
0.63
5.23
2.6
3.3
mg/l
31.9
277.2
2.40
87
1173
(3018418) pH of Serum or Plasma
229
1743
1.47
5.12
3.5
4.0
ph
7.4
7.4
0.06
27
332
(3011397) Hemoglobin [Presence] in Urine by Test strip
173
1247
1.52
5.05
4.6
4.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
328
2690
1.42
4.82
5.6
6.1
mmol/l
1.2
1.2
1.50
300
2422
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
352
2923
1.41
4.81
5.8
7.0
mmol/l
1.2
1.2
3.53
300
2462
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
24
4.64
4.79
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
130
1823
0.65
4.75
2.5
3.2
mmol/l
7.4
7.2
0.35
116
1487
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
84
516
1.71
4.73
2.6
2.5
u/l
33.2
33.1
0.02
71
435
(36304419) Bacteria [Presence] in Urine
209
1587
1.45
4.66
3.4
3.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
137
2.32
4.44
1.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
137
2.32
4.44
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
22
4.60
4.31
1.1
1.2
—
—
—
0
0
(3013512) EKG study
134
1828
0.67
4.19
3.2
4.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
267
2159
1.38
4.07
3.6
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
158
1170
1.45
3.95
5.5
4.5
kg/l
1.0
1.0
0.66
27
176
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
461
5091
0.72
3.94
4.6
5.1
mmol/l
6.1
6.1
0.21
421
4533
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
145
1059
1.47
3.89
2.9
3.0
e6/l
1.9
1.1
0.95
66
645
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
138
1001
1.47
3.83
3.0
3.2
e6/l
4.8
2.1
0.69
59
593
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
159
1187
1.44
3.80
4.0
4.2
ng/l
373.3
294.4
0.18
136
1010
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
9
7.84
3.56
1.4
1.9
umol/l
27.2
14.7
—
7
9
(3021440) Promyelocytes/100 leukocytes in Blood
20
443
0.44
3.50
2.8
4.0
%
0.3
0.1
—
7
135
(3022145) Colonoscopy Study observation
33
612
0.52
3.49
1.0
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
213
2612
0.73
3.45
3.8
4.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
211
1682
1.37
3.40
3.5
3.4
e6/l
0.4
0.6
1.70
149
1297
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
257
0.34
3.36
1.4
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
421
0.44
3.34
4.1
4.0
%
0.0
0.8
—
5
116
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
48
2.96
3.31
1.1
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
35
184
1.95
3.30
2.7
3.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
19
4.78
3.24
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
105
1435
0.68
3.21
1.6
1.7
mmol/l
1.5
1.3
0.91
89
1158
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
28
3.61
3.20
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
43
718
0.57
3.19
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
50
795
0.60
3.08
1.2
1.3
iu/ml
13.1
37.3
4.24
15
257
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
757
0.59
3.04
1.3
1.3
u/ml
1.5
12.6
3.80
13
256
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
21
4.33
3.00
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
41
235
1.79
2.99
2.3
3.1
pmol/l
4.1
4.4
0.83
32
204
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
168
2093
0.74
2.91
2.7
3.2
ng/l
784.6
1862.7
11.53
140
1816
(3018095) Leukocytes [#/volume] in Urine
249
2076
1.31
2.88
4.2
4.0
e6/l
89.6
124.6
0.41
167
1551
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
42
685
0.59
2.86
3.0
4.2
ug/l
17.2
36.1
0.58
37
577
(3033658) Prothrombin time (PT) actual/Normal
178
1418
1.34
2.82
4.1
4.0
%
89.5
85.3
1.36
170
1387
(3002179) Metamyelocytes/100 leukocytes in Blood
21
420
0.48
2.82
3.8
3.8
%
1.0
0.4
—
7
107
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
36
3.09
2.82
1.3
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
223
1839
1.31
2.77
3.5
3.5
e6/l
69.7
114.5
0.48
157
1455
(3041096) Erythrocytes [Presence] in Urine by Automated
104
1389
0.70
2.76
4.1
3.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
25
125
2.04
2.74
2.6
2.8
umol/l
32.4
33.1
0.06
18
102
(21494755) Public health laboratory ask at order entry panel
7
201
0.34
2.70
1.3
1.4
—
—
—
0
0
(4027681)
9
24
3.78
2.68
1.4
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
26
474
0.53
2.64
3.5
3.9
%
1.6
0.9
0.79
11
148
(3026493) Urate [Moles/volume] in Serum or Plasma
115
1491
0.73
2.54
2.2
2.9
umol/l
8012.5
9262.0
0.08
85
1252
(4035726)
30
517
0.56
2.52
1.2
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
163
1304
1.33
2.49
1.6
1.8
pmol/l
461.0
15067609.6
1.06
132
1042
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
159
0.31
2.44
1.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
53
346
1.58
2.43
1.6
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
196
2341
0.77
2.41
8.1
10.0
e9/l
0.0
0.0
0.46
143
1908
(3006270) Folate [Moles/volume] in Blood
12
46
2.64
2.37
1.3
1.2
nmol/l
253.9
327.3
0.76
12
39
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
482
0.56
2.36
1.4
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
180
2168
0.77
2.35
2.8
2.8
ug/l
136.1
155.1
0.62
163
1942
(3037756) Immunofixation for Serum or Plasma
5
154
0.32
2.30
2.0
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
42
2.65
2.19
1.3
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
31
181
1.75
2.19
1.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
43
2.58
2.10
1.3
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
190
0.41
2.08
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
339
0.52
2.07
2.2
4.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
74
538
1.42
2.05
4.5
8.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
58
0.00
2.04
0.0
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
104
1326
0.75
2.03
2.4
3.1
ug/l
1.0
0.8
0.39
80
919
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
764
0.68
1.98
2.9
4.9
%
34.0
32.3
0.43
37
492
(3027008) Opiates [Presence] in Urine
11
45
2.47
1.93
1.3
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
45
2.47
1.93
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
45
2.47
1.93
1.3
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
64
873
0.71
1.92
2.2
2.5
%
21.5
21.8
0.06
56
748
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
121
1.84
1.90
1.1
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
121
970
1.30
1.81
1.5
2.0
s
29.6
29.9
0.19
114
940
(40768797) Stomach Pathology biopsy report
54
750
0.70
1.80
1.4
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
151
0.39
1.78
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
95
739
1.33
1.77
11.7
7.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
18
3.35
1.75
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
13
255
0.50
1.73
3.9
3.4
u/ml
214.8
15877.9
—
6
217
(3003694) ABO and Rh group [Type] in Blood
102
1274
0.77
1.71
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
68
900
0.73
1.71
1.9
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
518
5450
0.81
1.68
10.1
11.3
u/l
24.0
24.9
0.59
490
5219
(3022621) pH of Urine by Test strip
24
388
0.60
1.65
5.2
3.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
32
2.52
1.60
2.1
2.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
159
0.43
1.56
1.6
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
48
655
0.71
1.47
1.3
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
59
440
1.37
1.46
1.6
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
34
491
0.68
1.43
2.6
3.6
mmol/l
1.2
1.2
0.10
29
429
(3026782) Osmolality of Urine
144
1215
1.23
1.42
2.6
3.1
mosm/kgh2o
554.4
550.6
0.07
123
1037
(1761482) Bacteria [#/volume] in Urine by Culture
10
199
0.50
1.42
2.2
5.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
79
993
0.77
1.40
2.2
2.5
umol/l
11.9
12.2
0.13
68
924
(3004789) Transferrin [Mass/volume] in Serum or Plasma
72
915
0.76
1.39
2.2
2.5
g/l
2.2
2.3
0.20
59
854
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
161
0.49
1.37
1.6
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
536
5589
0.82
1.37
27.9
25.0
e9/l
7.1
6.8
1.48
511
5407
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
247
0.56
1.36
1.4
2.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
536
5588
0.82
1.36
27.8
25.0
e12/l
4.3
4.4
2.61
510
5406
(3024731) MCV [Entitic volume]
536
5588
0.82
1.36
27.7
24.9
fl
91.7
91.7
0.04
519
5480
(3000963) Hemoglobin [Mass/volume] in Blood
536
5588
0.82
1.36
28.0
25.2
g/l
131.1
133.3
2.69
519
5480
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
5
17
2.95
1.36
2.4
4.2
umol/l
27.2
31.2
—
5
12
(3035941) MCH [Entitic mass]
536
5587
0.82
1.35
27.7
24.9
pg
30.5
30.4
0.31
519
5479
(3007461) Platelets [#/volume] in Blood
536
5586
0.82
1.34
27.8
25.0
e9/l
242.9
240.5
0.37
513
5423
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
459
0.68
1.31
2.1
3.1
ml/min/173m2
74.8
58.8
0.90
12
201
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
173
0.51
1.30
1.6
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
62
476
1.33
1.30
3.1
3.9
ng/l
77.6
90.3
0.68
49
416
(3020891) Body temperature
36
252
1.45
1.29
10.6
4.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
75
594
1.29
1.27
2.9
3.7
mmol/l
2.4
2.0
0.50
63
468
(3000850) Epithelial cells [#/volume] in Urine
151
1296
1.21
1.27
2.7
2.7
e6/l
7.4
4.7
0.67
135
1141
(3003338) MCHC [Mass/volume]
431
4043
1.17
1.26
27.4
22.9
g/l
331.6
331.3
0.26
417
4010
(40768443) Skin Pathology biopsy report
15
253
0.58
1.26
1.1
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
25
2.41
1.24
1.2
1.6
promille
0.4
1.4
—
6
19
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
36
2.24
1.24
2.4
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
141
0.49
1.22
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
58
446
1.33
1.21
1.6
2.1
nmol/l
375.4
376.3
0.01
50
404
(3037467) Urinalysis macro (dipstick) panel - Urine
399
3730
1.16
1.19
5.0
4.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
260
0.61
1.17
1.7
1.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
33
0.00
1.16
0.0
1.3
—
63.5
—
0
21
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
154
0.51
1.15
1.3
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
136
0.51
1.10
2.1
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
31
2.27
1.10
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
152
1.53
1.10
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
33
453
0.71
1.09
5.0
4.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
153
1.52
1.07
1.2
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
70
860
0.79
1.06
1.3
1.5
g/l
2.1
2.6
2.57
33
506
(42529406) Shigella sp [Presence] in Stool by Culture
23
154
1.51
1.05
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
111
943
1.21
1.04
2.6
3.3
mmol/l
0.8
0.8
0.77
99
882
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
8
150
0.53
1.04
1.9
1.5
—
0.4
—
0
30
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
575
1.26
1.04
3.4
2.6
ug/l
8.3
6.7
0.20
57
499
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
121
1398
0.84
1.01
2.3
2.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
9
157
0.57
0.99
1.0
1.5
g/l
1.3
1.2
—
9
149
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
405
3821
1.14
0.98
4.4
3.8
pmol/l
14.7
15.1
1.75
370
3369
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
23
2.18
0.98
4.4
5.5
—
—
—
0
0
(44806420)
0
29
0.00
0.98
0.0
2.3
—
—
—
0
0
(4211845)
0
29
0.00
0.98
0.0
3.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.6
—
1.0
—
0
30
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.2
—
1.2
—
0
12
(3011412) CD3 cells [#/volume] in Blood
0
31
0.00
0.96
0.0
2.1
—
0.8
—
0
15
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
397
0.72
0.96
1.9
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
152
1340
1.17
0.95
5.8
6.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
125
1.53
0.95
3.1
4.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
51
1.77
0.95
1.0
1.3
nmol/l
—
—
—
0
0
(3022313) Gas panel - Capillary blood
22
314
0.69
0.93
3.5
4.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
228
2490
0.87
0.91
4.8
5.9
%
8.6
8.9
0.91
207
2305
(3003434) Protein [Mass/volume] in Pleural fluid
5
104
0.48
0.89
1.0
1.5
g/l
25.0
29.4
—
5
95
(40768800) Prostate Pathology biopsy report
9
156
0.57
0.89
1.1
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
8
42
1.92
0.88
1.0
1.1
nmol/l
—
2.7
—
0
8
(3002030) Lymphocytes/100 leukocytes in Blood
232
2525
0.88
0.88
4.6
5.8
%
24.5
26.1
1.23
210
2319
(3010421) pH of Blood
22
153
1.45
0.86
3.8
4.5
ph
7.4
7.4
0.16
16
126
(3037121) Protein [Mass/volume] in Urine
15
227
0.65
0.85
2.9
2.8
g/l
0.1
0.3
—
7
89
(3006504) Eosinophils/100 leukocytes in Blood
228
2479
0.88
0.84
4.5
5.6
%
2.6
2.9
0.96
209
2289
(3030981) Hyaline casts [#/volume] in Urine by Automated count
27
364
0.73
0.83
2.7
2.9
e6/l
0.8
0.3
0.34
27
355
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
114
0.52
0.83
1.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
115
0.52
0.83
1.7
1.8
nmol/l
38.5
42.9
—
6
107
(3022096) Basophils/100 leukocytes in Blood
223
2423
0.88
0.81
4.5
5.6
%
0.6
0.6
0.06
204
2241
(3045414) Leukocytes [Presence] in Urine
16
235
0.67
0.80
1.7
1.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
9
150
0.59
0.79
1.0
1.5
g/l
0.3
0.2
—
9
142
(3037556) Urate [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
24
0.00
0.79
0.0
1.1
—
23.1
—
0
18
(3028433) Virus identified in Specimen by Culture
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
25
0.00
0.79
0.0
3.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
25
0.00
0.79
0.0
1.3
—
1.7
—
0
6
(3003396) Base excess in Arterial blood by calculation
88
754
1.19
0.79
6.1
7.3
mmol/l
1.0
1.3
0.17
66
592
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.1
—
101.8
—
0
19
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
4.2
—
0
12
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.1
—
33.3
—
0
19
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
1.0
—
0
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
96
0.52
0.78
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
97
0.51
0.78
2.8
2.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
28
0.00
0.76
0.0
4.8
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
28
0.00
0.76
0.0
1.3
—
1.6
—
0
20
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
41
512
0.79
0.75
1.6
2.1
ug/g
180.9
163.4
0.13
29
406
(3018010) Neutrophils/100 leukocytes in Blood
230
2482
0.89
0.74
4.6
5.5
%
60.7
58.4
1.92
212
2296
(3014111) Lactate [Moles/volume] in Serum or Plasma
66
554
1.21
0.74
5.1
7.0
mmol/l
1.4
1.4
0.21
61
532
(3019060) Gas panel - Arterial blood
55
453
1.23
0.74
5.7
4.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
512
5279
0.89
0.71
17.0
16.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
26
342
0.75
0.71
3.2
2.8
e9/l
7.4
4.0
0.61
21
245
(40761535) Cells panel - Urine sediment
61
512
1.21
0.69
4.3
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
407
0.78
0.69
1.6
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
212
2289
0.89
0.68
4.4
5.5
ug/l
2.4
3.7
1.38
174
2024
(3023103) Potassium [Moles/volume] in Serum or Plasma
532
5467
0.89
0.67
23.6
20.5
mmol/l
4.0
4.0
4.07
512
5306
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
45
546
0.81
0.66
1.3
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
86
749
1.17
0.66
6.3
7.3
kpa
5.0
5.1
0.27
81
718
(40760888) Immunoglobulin light chains.free panel - Serum
11
166
0.66
0.65
2.0
4.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
86
750
1.17
0.65
6.3
7.2
kpa
11.2
11.6
0.30
81
720
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
8
127
0.63
0.64
1.9
3.5
u/ml
789.3
2330.2
—
8
119
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
641
0.83
0.64
4.4
3.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
302
0.75
0.63
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
16
222
0.71
0.62
1.8
3.9
mg/l
60.1
90.9
0.43
11
183
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
16
222
0.71
0.62
1.8
4.0
mg/l
26.1
51.6
1.14
11
186
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
104
0.57
0.62
2.0
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
243
2592
0.90
0.62
6.1
11.3
inr
1.2
1.3
1.69
48
714
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
20
0.00
0.60
0.0
1.7
—
84193.8
—
0
13
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
20
0.00
0.60
0.0
2.0
—
16.6
—
0
10
(3036670) Protein [Mass/volume] in Synovial fluid
0
20
0.00
0.60
0.0
1.4
—
37.1
—
0
12
(3013727) Leukocytes other/100 leukocytes in Blood
0
20
0.00
0.60
0.0
5.0
—
49.4
—
0
20
(3019550) Sodium [Moles/volume] in Serum or Plasma
532
5455
0.89
0.59
23.8
20.4
mmol/l
139.7
139.6
0.20
512
5298
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
2.3
—
1012.5
—
0
22
(3008536) Aspergillus sp Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
93
1046
0.87
0.58
3.8
4.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
113
0.62
0.58
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
39
472
0.82
0.57
1.6
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
55
1.46
0.56
1.1
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
89
0.56
0.56
1.4
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
170
1836
0.90
0.55
2.5
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
179
1658
1.11
0.55
2.9
3.2
u/l
34.5
32.6
0.16
164
1581
(3051651) Icteric interference index of Serum or Plasma
6
38
1.58
0.54
4.8
3.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
30
370
0.80
0.53
1.7
2.2
nmol/l
11.2
12.5
0.34
21
317
(3051611) Lipemic interference index of Serum or Plasma
9
63
1.43
0.52
4.0
3.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
96
0.62
0.52
1.2
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
100
0.60
0.52
2.3
5.7
—
190.3
—
0
15
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
100
0.60
0.52
1.0
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
29
233
1.26
0.51
9.0
3.7
mmol/l
1.5
1.4
0.39
29
227
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
40
1.50
0.51
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
40
1.50
0.51
1.5
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
275
2608
1.09
0.51
4.6
4.0
estimate
0.0
0.0
0.00
29
492
(3013650) Neutrophils [#/volume] in Blood by Automated count
293
3075
0.92
0.51
7.9
8.7
e9/l
4.8
4.2
2.05
244
2670
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
258
2442
1.09
0.50
2.7
2.3
—
—
—
0
0
(3044889) 12 lead EKG panel
370
3842
0.92
0.49
4.1
4.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
226
1.25
0.48
1.6
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
137
1.32
0.47
2.1
2.3
g/l
135.0
126.8
0.57
12
99
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
200
1.26
0.47
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
35
416
0.83
0.45
3.4
3.9
ph
7.4
7.4
—
6
45
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
85
942
0.89
0.44
1.2
1.2
u/ml
1.5
1.4
0.05
19
224
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
129
0.69
0.43
1.1
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
33
277
1.20
0.42
1.3
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
1.6
—
0
10
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
194
0.77
0.41
1.5
1.7
—
100.0
—
0
9
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.1
—
1.2
—
0
11
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
17
0.00
0.40
0.0
1.2
—
5.5
—
0
12
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
9.2
—
0
17
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
382
3942
0.93
0.40
3.3
4.2
mm/h
12.9
14.5
1.22
343
3586
(3017569) Oxygen content in Arterial blood
5
34
1.47
0.40
1.8
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
292
0.82
0.40
2.8
3.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
160
0.75
0.40
1.6
2.5
ug/min
54.8
105.6
—
7
95
(3029075) Extractable nuclear Ab panel - Serum
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
18
0.00
0.40
0.0
2.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
251
2628
0.93
0.40
4.6
5.4
e9/l
0.0
0.0
0.17
200
2244
(3021788) Differential panel - Synovial fluid
7
104
0.67
0.39
1.6
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
193
0.77
0.39
1.1
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
19
0.00
0.39
0.0
2.5
—
100.8
—
0
19
(3001604) Monocytes [#/volume] in Blood
250
2615
0.93
0.38
4.6
5.4
e9/l
0.6
0.6
0.20
197
2222
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
174
1844
0.92
0.38
4.0
4.6
%
22.2
21.5
0.22
83
955
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
112
0.71
0.37
1.1
1.1
—
13.2
—
0
8
(3019230) Fractional oxyhemoglobin in Venous blood
8
114
0.70
0.37
1.8
2.0
%
48.4
60.8
—
8
114
(4094501)
17
134
1.28
0.37
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
1.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
70
1.29
0.36
1.2
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
261
2721
0.93
0.36
5.3
5.6
e9/l
0.2
0.2
0.05
215
2361
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
76
0.66
0.36
1.0
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
78
0.64
0.35
2.2
5.3
mg/l
11.1
11.9
—
5
72
(3035320) C reactive protein [Mass/volume] in Body fluid
6
42
1.43
0.35
5.2
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
134
0.74
0.35
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
457
0.87
0.35
1.6
2.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
16
127
1.27
0.33
3.3
4.8
mmol/l
2.9
2.7
0.07
11
85
(4034850)
21
173
1.22
0.33
16.9
11.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
87
0.69
0.33
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
317
3067
1.06
0.32
4.0
3.2
u/l
50.3
56.9
0.54
294
2797
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
169
1781
0.93
0.32
2.7
2.5
u/l
50.0
57.1
2.43
157
1640
(3021601) Nitrite [Presence] in Urine by Test strip
271
2610
1.06
0.32
5.8
5.5
estimate
0.0
0.0
0.00
31
484
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
53
1.32
0.31
1.4
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
257
2664
0.94
0.29
4.7
5.5
e9/l
1.8
1.9
0.23
210
2317
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
21
177
1.19
0.27
1.8
3.3
g/l
0.0
0.0
0.00
15
161
(3003327) Ova and parasites identified in Stool by Light microscopy
11
139
0.79
0.27
1.5
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
35
393
0.88
0.26
3.4
4.0
mmol/l
2.3
1.9
0.27
24
307
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
254
1.15
0.25
1.7
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
170
0.82
0.25
1.6
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
159
0.81
0.25
1.2
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
273
2649
1.05
0.24
4.6
4.1
estimate
0.0
0.0
0.00
30
478
(3045424) Erythrocytes [Presence] in Urine
6
81
0.74
0.24
1.0
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
21
180
1.17
0.24
1.8
3.3
g/l
0.0
0.0
0.00
15
162
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
22
190
1.16
0.23
1.8
3.2
g/l
0.0
0.0
0.50
16
172
(3020630) Protein [Mass/volume] in Serum or Plasma
50
545
0.91
0.23
1.5
3.1
g/l
65.9
65.8
0.02
39
493
(3029937) Albumin [Presence] in Urine by Test strip
152
1455
1.06
0.22
5.8
4.3
estimate
0.0
0.0
0.50
27
468
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
135
0.81
0.22
1.4
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
37.3
—
0
11
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
11
0.00
0.21
0.0
3.2
—
6872.5
—
0
11
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
5.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
12
0.00
0.21
0.0
3.3
—
126.5
—
0
12
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
2.3
—
0
6
(3013826) Glucose [Moles/volume] in Serum or Plasma
345
3376
1.04
0.21
5.5
4.9
mmol/l
6.9
6.8
0.51
318
3190
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
8.5
—
—
—
0
0
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
81
762
1.07
0.21
1.5
2.5
%
1.9
1.8
0.47
71
681
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
14
0.00
0.20
0.0
1.6
—
5.4
—
0
7
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
16.7
—
0
9
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
336
1.11
0.20
3.0
10.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
75
797
0.93
0.20
4.5
5.5
mmol/l
1.0
1.0
0.93
66
739
(3007853) Bacteria identified in Skin by Aerobe culture
62
663
0.93
0.19
1.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.3
1.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
430
4233
1.04
0.19
6.3
7.7
u/l
80.1
81.1
0.14
400
3937
(3035637) Corticotropin [Mass/volume] in Plasma
6
53
1.13
0.18
1.0
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
6
53
1.13
0.18
1.3
1.1
u/l
103.8
52.3
—
6
39
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
59
1.19
0.18
1.7
1.3
iu/l
39.1
30.2
—
7
50
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
258
0.89
0.18
1.7
2.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
258
0.89
0.18
1.7
2.9
g/l
7.2
7.6
0.49
15
186
(3005570) Glucose [Moles/volume] in Urine
7
60
1.17
0.18
2.3
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
257
0.89
0.17
1.7
2.9
g/l
4.2
3.7
0.38
15
179
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
68
1.18
0.16
1.1
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
113
1177
0.95
0.16
1.7
1.7
mg/l
1.5
1.4
0.13
88
932
(3022806) Fractional oxyhemoglobin in Capillary blood
6
76
0.79
0.15
1.3
1.9
%
90.0
89.3
—
6
76
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
76
0.79
0.15
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
79
0.76
0.15
2.7
1.4
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
80
0.75
0.15
2.2
2.8
—
592.7
—
0
10
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
80
0.75
0.15
2.3
3.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
157
1522
1.04
0.15
2.5
2.2
mg/l
3.1
3.2
0.10
137
1274
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
81
1.11
0.15
1.2
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
220
2149
1.03
0.14
2.2
2.2
nmol/l
77.7
79.1
0.28
192
1860
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
241
2358
1.03
0.14
4.5
4.1
ng/l
26.9
46.3
4.52
186
1830
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
33
305
1.09
0.14
3.9
2.4
%
0.7
0.7
0.45
33
295
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
98
0.81
0.13
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
138
0.87
0.13
1.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
108
0.83
0.13
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
239
0.92
0.10
1.8
2.9
g/l
9.4
10.4
0.67
14
201
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
472
4680
1.03
0.10
5.5
4.7
mu/l
2.2
2.0
0.27
426
4139
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
22
203
1.09
0.09
1.8
3.0
g/l
40.2
36.7
2.18
14
170
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.2
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
87
1.15
0.09
1.5
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
145
1.11
0.09
1.6
2.7
—
—
—
0
0
(4024509)
5
48
1.04
0.09
1.8
1.5
—
—
—
0
0
(3019225) pH of Specimen
64
616
1.04
0.09
3.8
4.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
227
0.92
0.09
2.5
2.4
u/ml
0.5
0.4
—
10
133
(3000093) Morphology [Interpretation] in Blood Narrative
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
61
0.82
0.08
2.6
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
61
0.82
0.08
1.0
3.3
nmol/l
8.5
6.1
—
5
61
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
62
0.81
0.08
1.8
2.5
—
—
—
0
0
(44790047)
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
(44790048)
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
(44806118)
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
(44790049)
5
65
0.77
0.08
1.6
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
70
0.86
0.07
1.3
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
570
0.96
0.07
1.5
2.6
e9/l
74.8
67.9
0.58
39
455
(4010399)
38
397
0.95
0.07
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
482
1.04
0.07
1.2
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
23
216
1.07
0.07
1.7
3.3
g/l
0.6
1.3
0.47
15
185
(3001019) Free T4 and TSH panel - Serum or Plasma
8
95
0.84
0.06
2.3
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
142
0.91
0.06
1.3
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
55
567
0.97
0.06
4.5
7.1
mmol/l
11.1
11.2
0.03
46
536
(36660697) Celiac disease serology panel - Serum
31
324
0.95
0.05
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
438
4403
0.99
0.05
22.3
18.9
%
39.2
38.6
0.75
273
2775
(3028626) Oxygen [Partial pressure] in Capillary blood
14
150
0.93
0.04
2.6
2.7
kpa
7.9
7.9
0.04
14
135
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
200
2019
0.99
0.04
5.1
4.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
300
2981
1.01
0.04
4.5
6.3
umol/l
12.2
12.0
0.09
276
2832
(1002224) Polysomnography panel
14
149
0.94
0.03
1.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
32
311
1.03
0.02
3.9
3.4
mmol/l
25.3
25.1
0.09
32
304
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
32
329
0.97
0.02
2.2
2.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
517
5158
1.01
0.02
19.4
17.0
mg/l
29.1
26.5
0.94
429
4173
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
238
0.97
0.02
1.7
3.0
g/l
3.0
3.2
0.89
15
183
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
103
1.07
0.02
2.6
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
107
0.93
0.02
1.4
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
36
352
1.02
0.01
5.9
9.6
mmol/l
24.1
24.7
0.33
31
331
(3002385) Erythrocyte distribution width [Ratio]
411
4103
1.00
0.00
23.4
21.0
%
13.8
13.9
0.74
396
4014
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
102
0.98
0.00
1.2
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
242
0.99
0.00
1.0
1.1
iu/ml
55.7
127.3
—
8
83
(42870588) Differential panel, method unspecified - Blood
183
1834
1.00
0.00
4.2
5.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
101
0.99
0.00
1.1
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
119
1.01
0.00
2.5
2.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
64
638
1.00
0.00
2.4
3.0
umol/l
10.5
9.4
0.15
52
571
(3000492) Spirometry study
42
421
1.00
0.00
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
78
0.90
0.00
1.6
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.0
1.9
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
78
0.90
0.00
1.6
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
78
0.90
0.00
1.6
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
78
0.90
0.00
1.6
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
86.7
—
0
7
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
12.0
—
0
5
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
105.4
—
0
9
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.0
1.9
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
2.0
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
10.9
—
6.8
—
0
8
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
73
0.96
0.00
2.0
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
4.1
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
66
0.91
0.00
1.3
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
8.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
82
0.98
0.00
1.0
2.2
pg
32.0
32.5
—
8
82
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
84.5
—
0
8
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
79
0.88
0.00
1.6
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
52
0.96
0.00
2.2
1.6
%
8.4
10.5
—
5
52
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_ATROPHCIRCUM and mortality.

Females

Parameter HR [95% CI] p-value
G6_ATROPHCIRCUM 3.807 [3.24, 4.47] < 0.001
Birth year 0.996 [0.99, 1.0] 0.335

During the follow-up period (1.1.1998 — 31.12.2019), 1496 out of 2867 females with G6_ATROPHCIRCUM died.

Males

Parameter HR [95% CI] p-value
G6_ATROPHCIRCUM 3.818 [3.16, 4.61] < 0.001
Birth year 0.991 [0.98, 1.0] 0.052

During the follow-up period (1.1.1998 — 31.12.2019), 1262 out of 2230 males with G6_ATROPHCIRCUM died.

Mortality risk

Mortality risk for people of age

years, who have G6_ATROPHCIRCUM.

N-year risk Females Males
1 0.352% 0.706%
5 2.162% 4.74%
10 5.576% 11.668%
15 10.637% 21.832%
20 18.658% 34.354%

Relationships between endpoints

↥

Index endpoint: G6_ATROPHCIRCUM – Circumscribed brain atrophy

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data